Endomyocardial and pericardial aspergillosis in critically ill patients

Mycoses
George DimopoulosAspICU investigators

Abstract

Invasive aspergillosis(IA) is a potentially lethal complication of Aspergillus infection affecting mainly immunocompromised hosts; however, during the last two decades its incidence was increasingly observed in critically ill immunocompetent patients. The objective of this study is to describe the clinical characteristics of histologically proven endomyocardial and pericardial invasion, in the context of IA, in critically ill patients. Eight critically ill patients with histopathological confirmation of endomyocardial/pericardial aspergillosis were evaluated. Risk factors, clinical and laboratory characteristics, treatment, histopathological characteristics and mortality were recorded. Signs and symptoms of cardiac dysfunction were not observed in any of the patients. Therapy was administered to six of them shortly after the first positive culture. The observed histopathological lesions included haemorrhagic lesions, small vessels with central thrombosis and surrounding consolidated tissue with necrosis. Voriconazole, caspofungin, lipid amphotericin B and itraconazole were the used antifungals. The mortality rate was high (87.5%). Endomyocardial and pericardial aspergillosis are devastating complications of invasive aspergillos...Continue Reading

References

Jan 1, 1997·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M VogeserG Ruckdeschel
Mar 21, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V Le MoingP Casassus
Apr 20, 2001·Internal Medicine·K KobayashiT Tokushima
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AsciogluUNKNOWN Mycoses Study Group of the National Institute of Allergy and Infectious Diseases
Apr 8, 2003·Journal of Chemotherapy·G DimopoulosJ L Vincent
Jan 9, 2004·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Hassan Chamsi-PashaAbdullah K Ashmeg
Feb 1, 2005·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Vedat DavutogluMetin Karakok
Jul 1, 2005·Critical Care : the Official Journal of the Critical Care Forum·José Garnacho-MonteroFernando Barcenilla
Feb 6, 2007·American Journal of Clinical Pathology·Theodouli StergiopoulouThomas J Walsh
Jul 25, 2007·Intensive Care Medicine·R J TrofA B J Groeneveld
Jan 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas J WalshUNKNOWN Infectious Diseases Society of America
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Dec 19, 2009·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Pradeep Vaideeswar
Oct 12, 2011·Immunological Investigations·David A Stevens, George L Melikian
Apr 21, 2012·American Journal of Respiratory and Critical Care Medicine·Stijn I BlotUNKNOWN AspICU Study Investigators
May 19, 2012·Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology·Sílvia RibeiroAdelino Correia
May 1, 2015·Critical Care : the Official Journal of the Critical Care Forum·Fabio Silvio TacconeUNKNOWN AspICU Study Investigators

❮ Previous
Next ❯

Citations

Jul 31, 2019·Current Opinion in Critical Care·Stijn BlotDespoina Koulenti
Sep 24, 2019·Saudi Journal of Medicine & Medical Sciences·Feras Ahmed AlkuwaitiSaleh Tawfeeq Alshreadah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.